254 related articles for article (PubMed ID: 21690334)
1. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of licensed vaccine adjuvants.
Tritto E; Mosca F; De Gregorio E
Vaccine; 2009 May; 27(25-26):3331-4. PubMed ID: 19200813
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.
Ellebedy AH; Lupfer C; Ghoneim HE; DeBeauchamp J; Kanneganti TD; Webby RJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2927-32. PubMed ID: 21270336
[TBL] [Abstract][Full Text] [Related]
4. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination.
Vono M; Taccone M; Caccin P; Gallotta M; Donvito G; Falzoni S; Palmieri E; Pallaoro M; Rappuoli R; Di Virgilio F; De Gregorio E; Montecucco C; Seubert A
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21095-100. PubMed ID: 24324152
[TBL] [Abstract][Full Text] [Related]
5. MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine.
Granoff DM; McHugh YE; Raff HV; Mokatrin AS; Van Nest GA
Infect Immun; 1997 May; 65(5):1710-5. PubMed ID: 9125551
[TBL] [Abstract][Full Text] [Related]
6. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
[TBL] [Abstract][Full Text] [Related]
8. MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine.
Singh M; Kazzaz J; Ugozzoli M; Baudner B; Pizza M; Giuliani M; Hawkins LD; Otten G; O'Hagan DT
Hum Vaccin Immunother; 2012 Apr; 8(4):486-90. PubMed ID: 22832252
[TBL] [Abstract][Full Text] [Related]
9. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates.
Traquina P; Morandi M; Contorni M; Van Nest G
J Infect Dis; 1996 Dec; 174(6):1168-75. PubMed ID: 8940205
[TBL] [Abstract][Full Text] [Related]
10. An alternative renewable source of squalene for use in emulsion adjuvants.
Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
[TBL] [Abstract][Full Text] [Related]
11. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
12. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
[TBL] [Abstract][Full Text] [Related]
13. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
[TBL] [Abstract][Full Text] [Related]
14. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
[TBL] [Abstract][Full Text] [Related]
15. A clinically applicable adjuvant for an atherosclerosis vaccine in mice.
Kobiyama K; Vassallo M; Mitzi J; Winkels H; Pei H; Kimura T; Miller J; Wolf D; Ley K
Eur J Immunol; 2018 Sep; 48(9):1580-1587. PubMed ID: 29932463
[TBL] [Abstract][Full Text] [Related]
16. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
Eisenbarth SC; Colegio OR; O'Connor W; Sutterwala FS; Flavell RA
Nature; 2008 Jun; 453(7198):1122-6. PubMed ID: 18496530
[TBL] [Abstract][Full Text] [Related]
17. Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.
Lai RP; Seaman MS; Tonks P; Wegmann F; Seilly DJ; Frost SD; LaBranche CC; Montefiori DC; Dey AK; Srivastava IK; Sattentau Q; Barnett SW; Heeney JL
PLoS One; 2012; 7(4):e35083. PubMed ID: 22509385
[TBL] [Abstract][Full Text] [Related]
18. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
[TBL] [Abstract][Full Text] [Related]
19. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
Banzhoff A; Pellegrini M; Del Giudice G; Fragapane E; Groth N; Podda A
Influenza Other Respir Viruses; 2008 Nov; 2(6):243-9. PubMed ID: 19453401
[TBL] [Abstract][Full Text] [Related]
20. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
Valensi JP; Carlson JR; Van Nest GA
J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
